It’s time to turn up the heat—scientists in Finland have released evidence that frequent sauna bathing can decrease risk factors for men diagnosed with hypertension.

PLAINSBORO, N.J., Sept. 29, 2017 — Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) approved Fiasp® (insulin aspart injection) 100 Units/mL, a fast-acting mealtime insulin indicated to improve glycemic control in adults with type 1 and type 2 diabetes.

Severely obese patients who underwent gastric bypass surgery showed favorable outcomes more than a decade later, including weight loss and remission of type 2 diabetes, a study published in the New England Journal of Medicine states.

The FDA has approved Abbott’s FreeStyle Libre Flash Glucose Monitoring System, the first personal continuous glucose monitor that doesn’t require finger stick calibration.

Knowledge and treatment of hypertension in susceptible patients might be expanding in the U.S. and other developed countries, but research has shown that trend doesn’t translate across socioeconomic borders.

Researchers studying a species of bats in Panama found the creatures can vary their heart rates from more than 1,000 beats per minute (BPM) when flying to 200 BPM when resting.

Researchers at Washington University School of Medicine in St. Louis have discovered a way to convert “bad” fat—the kind that accumulates around our stomachs, hips and thighs—into “good” fat, which helps to burn calories and generate heat, initiating what could be a novel treatment for obesity.

New research from the American Diabetes Association advises controlling symptoms of type 2 diabetes, including hyperglycemia and blood pressure control, may help prevent the decline of cognitive performance associated with the disease.